SCHEMBL6833709

SCHEMBL6833709

Cc1ccc2c(c1)nc(C(F)(F)F)c1nc(-c3ccco3)n(CCN3CCNCC3)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.36
KCNH2 Q12809 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
MAPT P10636 3/20 0.35
TSHR P16473 2/20 0.35
ADRB2 P07550 1/20 0.35
ADRA2A P08913 1/20 0.35
HTR2C P28335 1/20 0.35
AXL P30530 1/20 0.35
HTR2B P41595 1/20 0.35
HTR6 P50406 1/20 0.35
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
LMNA P02545 1/20 0.35
CREBBP Q92793 1/20 0.35
KDM4E B2RXH2 6/20 0.34
ALDH1A1 P00352 6/20 0.34
HPGD P15428 5/20 0.34
HSD17B10 Q99714 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838564 0.91 KCNH2 (0.37) HRH1KCNH2HRH4HRH3MAPT
SCHEMBL6838072 0.91 HRH1 (0.35) HRH1KCNH2HRH4HRH3MAPT
SCHEMBL6838074 0.87 ALDH1A1 (0.33) HRH1KCNH2HRH4HRH3MAPT
SCHEMBL6839980 0.86 ADRB2 (0.39) HRH1MAPTTSHRADRB2ADRA2A
SCHEMBL6838013 0.84 ADORA2A (0.35) LMNAKDM4EALDH1A1HSD17B10ADORA2A
SCHEMBL6833745 0.83 ADRB2 (0.35) HRH1KCNH2MAPTTSHRADRB2
SCHEMBL6837935 0.83 HTR6 (0.36) HRH1KCNH2MAPTTSHRADRB2
SCHEMBL6838548 0.83 SLC6A2 (0.32) HRH1KCNH2MAPTKDM4EALDH1A1
SCHEMBL6838063 0.81 ADRB2 (0.35) HRH1KCNH2MAPTTSHRADRB2
SCHEMBL6838592 0.80 ADRB2 (0.34) HRH1KCNH2MAPTTSHRADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 HRH1 667/4885KCNH2 383/4885HRH4 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.